What is BiObex?
Operating under the brand identity of SAFE Technology, BiObex provides a comprehensive suite of cybersecurity products engineered to fortify personal and enterprise information. The company's core offerings, including SAFE Password, SAFE Protected Files, and SAFE Protected Email, utilize advanced encryption and secure authentication protocols to mitigate digital threats. With a commitment to high-standard security, the firm integrates FIPS 140-2 Level 3 validation into its architecture, ensuring that both individual users and enterprise developers benefit from rigorous data protection. Their cross-platform compatibility across Windows and Mac OSX environments positions them as a versatile player in the global privacy and security sector.
How much funding has BiObex raised?
BiObex has raised a total of $27K across 1 funding round:
Debt
$27K
Debt (2021): $27K with participation from PPP
Key Investors in BiObex
PPP
Public-Private Partnership
What's next for BiObex?
With the recent infusion of capital, BiObex is expected to scale its operations significantly, focusing on the expansion of its enterprise-grade security services. The strategic roadmap likely involves enhancing its two-factor authentication capabilities and broadening its market reach to address the growing demand for robust data privacy tools. As the company transitions through its current growth phase, the focus will remain on maintaining technical superiority while scaling its infrastructure to support a larger, more diverse client base. This investment serves as a critical milestone in the company's evolution, providing the necessary resources to navigate the complex and rapidly shifting cybersecurity threat landscape.
See full BiObex company page
